Works matching IS 02698811 AND DT 2023 AND VI 37 AND IP 8

Results: 11

Ketamine: A new chapter for clinical psychopharmacology?

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 8, p. 755, doi. 10.1177/02698811231191912

By:

Young, Allan H

Publication type:

Article

Ketamine-induced changes in resting state connectivity, 2 h after the drug administration in patients with remitted depression.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 8, p. 784, doi. 10.1177/02698811231189432

By:

Burrows, Matthew;
Kotoula, Vasileia;
Dipasquale, Ottavia;
Stringaris, Argyris;
Mehta, Mitul A

Publication type:

Article

Hippocampal phase precession is preserved under ketamine, but the range of precession across a theta cycle is reduced.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 8, p. 809, doi. 10.1177/02698811231187339

By:

Speers, Lucinda J;
Sissons, Daena J;
Cleland, Lana;
Bilkey, David K

Publication type:

Article

Baseline cognitive function predicts full remission of suicidal symptoms among patients with treatment-resistant depression and strong suicidal ideation after low-dose ketamine infusion.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 8, p. 795, doi. 10.1177/02698811231182107

By:

Lin, Wei-Chen;
Su, Tung-Ping;
Li, Cheng-Ta;
Wu, Hui-Ju;
Tsai, Shih-Jen;
Bai, Ya-Mei;
Tu, Pei-Chi;
Chen, Mu-Hong

Publication type:

Article

The safety of repeated ketamine dosing in paediatrics: A systematic review.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 8, p. 757, doi. 10.1177/02698811231177240

By:

James, Lottie;
James, Ian G;
Wakefield, Justin

Publication type:

Article

Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 8, p. 775, doi. 10.1177/02698811231171531

By:

Chisamore, Noah;
Danayan, Kevork;
Rodrigues, Nelson B;
Di Vincenzo, Joshua D;
Meshkat, Shakila;
Doyle, Zoe;
Mansur, Rodrigo;
Phan, Lee;
Fancy, Farhan;
Chau, Edmond;
Tabassum, Aniqa;
Kratiuk, Kevin;
Arekapudi, Anil;
McIntyre, Roger S;
Rosenblat, Joshua D.

Publication type:

Article

Comment on 'Characteristics of poisonings involving ketamine in the United States, 2019–2021'.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 8, p. 845, doi. 10.1177/02698811231169647

By:

Pastuszak, Michał;
Wiglusz, Mariusz S

Publication type:

Article

Sub-anesthetic doses of ketamine increase single cell entrainment in the rat auditory cortex during auditory steady-state response.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 8, p. 822, doi. 10.1177/02698811231164231

By:

Munch, Anders Sonne;
Amat-Foraster, Maria;
Agerskov, Claus;
Bastlund, Jesper Frank;
Herrik, Kjartan Frisch;
Richter, Ulrike

Publication type:

Article

A transdiagnostic systematic review and meta-analysis of ketamine's anxiolytic effects.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 8, p. 764, doi. 10.1177/02698811231161627

By:

Hartland, Hannah;
Mahdavi, Kimia;
Jelen, Luke A;
Strawbridge, Rebecca;
Young, Allan H;
Alexander, Laith

Publication type:

Article

Characteristics of poisonings involving ketamine in the United States, 2019–2021.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 8, p. 802, doi. 10.1177/02698811221140006

By:

Palamar, Joseph J.;
Fitzgerald, Nicole D.;
Grundy, David J.;
Black, Joshua C.;
Jewell, Jennifer S.;
Cottler, Linda B.

Publication type:

Article

Commentary on Cochrane review: "Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder".

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 8, p. 836, doi. 10.1177/02698811221123046

By:

Borentain, Stephane;
Desai, Pooja;
Fu, Dong-Jing;
Nancy Chen, Li;
Lane, Rosanne;
Mathews, Maju;
Canuso, Carla M

Publication type:

Article